Biomea Fusion, Inc.(BMEA)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
BMEA Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Biomea Fusion, Inc. (BMEA), a Healthcare sector company. BMEA is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of BMEA by reported 13-F value include FMR, VANGUARD CAPITAL MANAGEMENT, MARSHALL WACE, LLP, based on the most recent SEC filings. BMEA trades on the Nasdaq exchange and files with the SEC under CIK 1840439. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BMEA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Biomea Fusion, Inc. directly from SEC EDGAR.
Net Income
Q2 2026
$-8.3M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
+55.4% YoYOperating Income
+42.0% YoYEPS (Diluted)
+69.2% YoYTotal Assets
-26.7% YoYOp. Cash Flow
+41.3% YoYFree Cash Flow
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Net Income | $-61.8M +55.4% | $-138.4M -18.1% | $-117.3M -43.3% | $-81.8M -96.9% | $-41.6M -680.7% | $-5.3M |
| Operating Income | $-83.5M +42.0% | $-144.1M -14.2% | $-126.1M -50.8% | $-83.6M -100.7% | $-41.7M -682.2% | $-5.3M |
| EPS (Diluted) | $-1.18 +69.2% | $-3.83 -11.3% | $-3.44 -22.9% | $-2.80 -60.9% | $-1.74 -2915.6% | $-0.06 |
| Total Assets | $58.6M -26.7% | $79.9M -60.0% | $199.9M +54.6% | $129.3M -30.4% | $185.7M +197.0% | $62.5M |
| Operating Cash Flow | $-70.4M +41.3% | $-119.9M -24.1% | $-96.6M -54.8% | $-62.4M -76.1% | $-35.4M -694.8% | $-4.5M |
| Free Cash Flow | — | $-120.3M -20.3% | $-100.0M -57.6% | $-63.4M -64.3% | $-38.6M -756.1% | $-4.5M |
Get alerted when BMEA's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Biomea Fusion, Inc. including:
Top Institutional Holders of BMEA
FMR LLC
$13.0M8,814,946 shVANGUARD CAPITAL MANAGEMENT LLC
$4.2M2,829,927 shMARSHALL WACE, LLP
$3.0M2,049,802 shAisling Capital Management LP
$3.0M2,048,757 shRENAISSANCE TECHNOLOGIES LLC
$2.1M1,455,474 shGROUP ONE TRADING, L.P.
$1.3M888,600 shFIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.
$1.1M723,176 shBlackRock, Inc.
$1.1M715,445 shGEODE CAPITAL MANAGEMENT, LLC
$1.0M708,854 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$900.7K612,735 sh
| Fund | Value | Shares |
|---|---|---|
| FMR LLC | $13.0M | 8,814,946 |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.2M | 2,829,927 |
| MARSHALL WACE, LLP | $3.0M | 2,049,802 |
| Aisling Capital Management LP | $3.0M | 2,048,757 |
| RENAISSANCE TECHNOLOGIES LLC | $2.1M | 1,455,474 |
| GROUP ONE TRADING, L.P. | $1.3M | 888,600 |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | $1.1M | 723,176 |
| BlackRock, Inc. | $1.1M | 715,445 |
| GEODE CAPITAL MANAGEMENT, LLC | $1.0M | 708,854 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $900.7K | 612,735 |
More Healthcare Companies
View all Healthcare →Put BMEA on your watchlist
Track score changes the day Biomea Fusion, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is BMEA a good stock to buy?
13F Pro's AI-powered analysis of Biomea Fusion, Inc. (BMEA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BMEA are available on the BMEA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. BMEA is classified as a small company.
Which hedge funds own BMEA?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BMEA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Biomea Fusion, Inc.'s investment landscape.